Atlas Trials

A Counter Measure for the Effects of Immune and Microbiome Changes in Environments With Limited ANtigen Diversity (ICELAND-TWO)

Clinical trial NCT03746145 · UNKNOWN

Trial details

NCT number
NCT03746145
Sponsor
University Hospital Tuebingen
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Confinement and Isolation
Start date
2018-11-15
Primary completion
2022-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.